Metronidazole caused profound drug‐induced immune thrombocytopenia

Metronidazole is commonly prescribed and has not been known to cause drug‐induced immune thrombocytopenia. We have provided clinical and laboratory evidence with DDabs that metronidazole can cause drug‐induced immune thrombocytopenia (DITP). Providers must be aware of metronidazole causing DITP beca...

Descripción completa

Detalles Bibliográficos
Autores principales: Lew, Jeffrey, Berenberg, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771911/
https://www.ncbi.nlm.nih.gov/pubmed/29375866
http://dx.doi.org/10.1002/ccr3.1334
_version_ 1783293320823308288
author Lew, Jeffrey
Berenberg, Jeffrey
author_facet Lew, Jeffrey
Berenberg, Jeffrey
author_sort Lew, Jeffrey
collection PubMed
description Metronidazole is commonly prescribed and has not been known to cause drug‐induced immune thrombocytopenia. We have provided clinical and laboratory evidence with DDabs that metronidazole can cause drug‐induced immune thrombocytopenia (DITP). Providers must be aware of metronidazole causing DITP because recognition of thrombocytopenia is critical and cessation of the drug should occur promptly.
format Online
Article
Text
id pubmed-5771911
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57719112018-01-26 Metronidazole caused profound drug‐induced immune thrombocytopenia Lew, Jeffrey Berenberg, Jeffrey Clin Case Rep Case Reports Metronidazole is commonly prescribed and has not been known to cause drug‐induced immune thrombocytopenia. We have provided clinical and laboratory evidence with DDabs that metronidazole can cause drug‐induced immune thrombocytopenia (DITP). Providers must be aware of metronidazole causing DITP because recognition of thrombocytopenia is critical and cessation of the drug should occur promptly. John Wiley and Sons Inc. 2017-12-15 /pmc/articles/PMC5771911/ /pubmed/29375866 http://dx.doi.org/10.1002/ccr3.1334 Text en Published 2017. This article is a U.S. Government work and is in the public domain in the USA. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Lew, Jeffrey
Berenberg, Jeffrey
Metronidazole caused profound drug‐induced immune thrombocytopenia
title Metronidazole caused profound drug‐induced immune thrombocytopenia
title_full Metronidazole caused profound drug‐induced immune thrombocytopenia
title_fullStr Metronidazole caused profound drug‐induced immune thrombocytopenia
title_full_unstemmed Metronidazole caused profound drug‐induced immune thrombocytopenia
title_short Metronidazole caused profound drug‐induced immune thrombocytopenia
title_sort metronidazole caused profound drug‐induced immune thrombocytopenia
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771911/
https://www.ncbi.nlm.nih.gov/pubmed/29375866
http://dx.doi.org/10.1002/ccr3.1334
work_keys_str_mv AT lewjeffrey metronidazolecausedprofounddruginducedimmunethrombocytopenia
AT berenbergjeffrey metronidazolecausedprofounddruginducedimmunethrombocytopenia

Ejemplares similares